Appendix 3B
October 22, 2019
Imagion Biosystems has announced “Appendix 3B, New issue announcement, application for quotation of additional securities and agreement.” Read Appendix 3B.
Category: Investor updates
Scientific Advisory Board Established as IBX Advances towards First-in-Human Study
October 14, 2019
MELBOURNE — Imagion Biosystems Limited (ASX: IBX) (the Company), a company dedicated to improving healthcare through the earlier detection of cancer, today announces appointments to
Appendix 3B
October 4, 2019
Imagion Biosystems Limited today announced “Appendix 3B New issue announcement, application for quotation of additional securities and agreement.” Read Appendix 3B.
Imagion Biosystems Investor Update
October 2, 2019
Imagion Biosystems is pleased to provide an update on its capital management and progress towards its first-in-human study, Read the Investor Update.
Notice Pursuant to Section 708A(5)(e) of the Corporations Act
September 30, 2019
Imagion Biosystems Limited has given notice under section 708A(5)(e) of the Corporations Act 2001. Read the notice.
Appendix 3B
September 30, 2019
Imagion Biosystems Limited has announced Appendix 3B, “New issue announcement, application for quotation of additional securities and agreement.” Read Appendix 3B.
Imagion Commences Non Deal Roadshow in Australia
September 10, 2019
Imagion Biosystems Limited (ASX:IBX) (the Company), a Company dedicated to improving healthcare through the earlier detection of cancer, is pleased to share the updated investor
Imagion presents positive new data at World Molecular Imaging Congress
September 9, 2019
Imagion presents positive new data at World Molecular Imaging Congress Study reports MagSense® utility as a potential MRI contrast agent MELBOURNE — Imagion Biosystems Limited
Appendix 4D and Half-Year Report
August 31, 2019
The following Appendix 4D and Half-Year Report has been lodged with ASX. Read Appendix 4D and Half-Year Report.
Biotech Daily — Dr Boreham's Crucible: Imagion Biosystems
August 28, 2019
Tim Boreham profiles Imagion Biosystems in this 5-1/2 page article. Read the profile.